semaglutide gastroparesis lawsuit in louisiana nausea class action glp-1 gi obstruction gastrointestinal gastric intestinal obstruction attorney louisiana Ozempic louisiana glp-1 gastroparesis legal team

Among the BS cohort, most participants were female, younger, white, and had a smoking history

Oral semaglutide (Rybelsus) was FDA-approved in 2019, while there is no FDA-approved oral tirzepatide at all Zepbound is an injection and the two routes carry distinct absorption requirements and clinical profiles that affect real-world effectiveness

HDL-4 p=7.73E-03)

Their customer service is outstanding

If the primary goal is weight loss without underlying metabolic conditions, lifestyle changes like diet and exercise may be more effective in the long run

Researchers have found significant associations between GLP-1RA use and improved neurological and behavioral outcomes